Chemtrade Logistics Income Fund TSE: CHE.UN expects adjusted EBITDA to rise in 2027, with lower sulphur costs potentially benefiting its water treatment business and no major turnaround scheduled at its North Vancouver chlor-alkali plant, executives said during the company’s third-quarter earnings call.
President and CEO Scott Rook declined to quantify the expected increase, saying the company would provide the magnitude in January. The call consisted of a question-and-answer session; the transcript did not include detailed third-quarter financial results.
Lower sulphur costs could benefit water business
Rook said sulphur prices had already fallen and that Chemtrade anticipated lower prices in 2027. Because the company generally sells water treatment chemicals at prices fixed for a year, lower sulphur costs could improve the business after price increases made during 2026.
The water business should also receive a full-year benefit from organic growth projects, Rook said. He expects water volumes to grow, while the company is investing in more specialized products that could improve margins even if overall volume growth is modest, CFO Rohit Bhardwaj added.
In the acid business, Rook expects regeneration, or Regen, operations to remain strong, with a possible modest increase in volume. He also anticipates a pickup in ultrapure acid, while merchant acid could moderate as sulphur prices decline.
Bhardwaj said merchant acid was the main source of strength offsetting weaker-than-expected electrochemicals pricing against the assumptions made at the start of 2026. He said the company can pass through higher sulphur costs and gain an additional benefit because some of its acid is produced as a byproduct rather than by burning sulphur. Corporate costs were also down substantially from the prior year, he said.
Electrochemicals outlook remains mixed
Rook said caustic soda pricing remains uncertain despite an industry forecast for higher prices. Chlorine is likely to remain weak, he said, while hydrochloric acid demand will depend on fracking activity.
The CEO expects continued slight annual volume declines in chlorate, which is used in pulp and paper. Caustic volumes at North Vancouver are relatively stable because the plant runs close to capacity, he said. Chemtrade can shift chlorine output toward hydrochloric acid, which it prefers to sell into the fracking industry.
Bhardwaj said a stronger fracking market could improve the product mix without necessarily increasing overall volume. He also said higher ocean shipping costs and efforts to price domestic caustic sales less directly against an index have helped protect economics in recent years.
Asked whether the company’s segments could remain free-cash-flow positive at the bottom of a commodity cycle, Bhardwaj said he saw a substantial buffer. He pointed to long-term cost-pass-through contracts in Regen, the structure of merchant acid contracts and the potential for water margins to improve when input costs fall.
North Vancouver review and capital spending
A judicial review filed against the District of North Vancouver could be heard around mid-2027, give or take a few months, with a decision potentially following three to four months later, Rook said. Chemtrade is not named in the review but is assisting the district, he said.
Rook said that timeline would be consistent with executing the company’s existing 2028 plans, although it could affect decisions on ordering long-lead-time equipment in 2027. Most of the work had been scheduled for 2028 and 2030, alongside the plant’s biennial turnarounds.
Discussing the previously disclosed CAD 75 million to CAD 125 million North Vancouver program, Rook said spending would be spread over roughly four or five years through 2030. Chemtrade intends to continue repurchasing units under its normal course issuer bid and investing in organic growth, with the scale guided by earnings and its leverage target of roughly 2.5 times, he said.
Ultrapure expansion and water acquisitions
Chemtrade has secured two ultrapure qualifications and is working on others, Rook said. He expects further approvals in 2027 but did not provide a specific timetable. Bhardwaj said ultrapure contribution margin should rise in 2027, although the pace depends on how quickly the approvals and customer ramps progress.
Rook said semiconductor fabrication plants are now coming online more quickly after earlier delays. Chemtrade is examining additional capacity at existing sites and considering what would be needed to restart efforts in Arizona, though he cautioned against reading too much into that work. He said the company sees a potential market opportunity for a world-scale plant.
For acquisitions, Rook said Chemtrade remains focused on water treatment, including potential additions to its product portfolio and services for municipal customers. The company’s longer-term strategy targets annual earnings growth of 5% to 10%, with roughly half expected from organic investments and half from acquisitions.
About Chemtrade Logistics Income Fund (TSE:CHE.UN)
Chemtrade operates a diversified business providing industrial chemicals and services to customers in North America and around the world. Chemtrade is one of North America's largest suppliers of sulphuric acid, spent acid processing services, inorganic coagulants for water treatment, sodium chlorate, sodium nitrite and sodium hydrosulphite. Chemtrade is also one of the largest producers of high purity sulphuric acid for the semiconductor industry in North America. Chemtrade is a leading regional supplier of sulphur, chlor-alkali products, and zinc oxide.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Chemtrade Logistics Income Fund, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Chemtrade Logistics Income Fund wasn't on the list.
While Chemtrade Logistics Income Fund currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.